Title : Inhibition of protein kinase CK2 by CX-5011 counteracts imatinib-resistance preventing rpS6 phosphorylation in chronic myeloid leukaemia cells: new combined therapeutic strategies.

Pub. Date : 2016 Apr 5

PMID : 26919095






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In imatinib-resistant CML cells, high concentration of imatinib is required to strongly inhibit Bcr-Abl, ERK1/2 and Akt Ser473 phosphorylation, but under these conditions the phosphorylation of rpS6, a common downstream effector of MEK/ERK1/2 and PI3K/Akt/mTOR pathways is only slightly reduced. Imatinib Mesylate mechanistic target of rapamycin kinase Homo sapiens